Source: Parambil
Parambil, an AI-driven legal tech company, has announced a $2M pre-seed funding round led by Daybreak Ventures. The funding will accelerate the company’s mission to transform complex litigation through high-quality, AI powered medical record analysis. Parambil’s products have already demonstrated higher accuracy than human reviewers and the company is supporting cases ranging from single event occurrences to some of the most notable and complex mass tort cases in the country.
“Our goal is to provide the legal industry with high-quality facts that enable more effective and efficient litigation,” said Sara Dwyer, Founder & CEO of Parambil. “We’re building the foundation for a future where AI not only improves outcomes but also transforms how firms manage data in complex cases.”
Parambil’s products have already proven to outperform human reviewers, delivering 44% more correct information and 70% fewer inaccuracies. These results translate into stronger plaintiff representation, better defense strategies, and faster and cheaper resolution for all parties involved. The company’s work spans mass torts, medical malpractice, catastrophic personal injury cases, and environmental exposure claims.
In 2024, Parambil achieved a key milestone by partnering with the leadership team of one of the largest and most complex mass torts cases in the U.S. Described by case leaders as “the most intricate litigation” they’ve encountered, this opportunity underscores the scalability and sophistication of Parambil’s platform. The company’s tools are now being piloted by dozens of national and regional participating law firms as part of the ongoing litigation in addition to its dedicated client roster.
Read the full article: https://www.parambil.com/resources/parambil-secures-2m-to-revolutionize-mass-torts-litigation-with-ai-launches-new-products-and-strategic-partnerships
